Tenaya Therapeutics, Inc. (TNYA) Financials

$1.11

south_east
-$0.02 (-1.77%)
Day's range
$1.07
Day's range
$1.19
$0$0-$50M-$50M-$100M-$100M-$150M-$150MEarning20192019202020202021202120222022202320233%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

TNYA Income statement / Annual

Last year (2023), Tenaya Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Tenaya Therapeutics, Inc.'s net income was -$124.08 M. See Tenaya Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $8.69 M $8.71 M $4.03 M $2.48 M $1.99 M
Gross Profit -$8.69 M -$8.71 M -$4.03 M -$2.48 M -$1.99 M
Gross Profit Ratio 0 0 0 0 0
Research and Development Expenses $98.04 M $94.54 M $54.39 M $31.10 M $23.15 M
General & Administrative Expenses $33.16 M $31.08 M $18.41 M $7.81 M $4.56 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $33.16 M $31.08 M $18.41 M $7.81 M $4.56 M
Other Expenses $0.00 $2,000.00 -$23,000.00 $430,000.00 $1.03 M
Operating Expenses $131.19 M $125.62 M $72.81 M $38.91 M $27.71 M
Cost And Expenses $131.19 M $125.62 M $72.81 M $38.91 M $27.71 M
Interest Income $7.06 M $1.95 M $108,000.00 $87,000.00 $453,000.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $8.69 M $8.71 M $4.03 M $2.48 M $1.99 M
EBITDA -$122.51 M -$114.95 M -$68.70 M -$36.43 M -$25.72 M
EBITDA Ratio 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0
Total Other Income/Expenses Net $7.11 M $1.96 M $85,000.00 $517,000.00 $1.48 M
Income Before Tax -$124.08 M -$123.67 M -$72.72 M -$38.40 M -$26.23 M
Income Before Tax Ratio 0 0 0 0 0
Income Tax Expense $0.00 -$1,956.00 -$3.07 M -$87,000.00 -$453,000.00
Net Income -$124.08 M -$123.66 M -$69.65 M -$38.31 M -$25.78 M
Net Income Ratio 0 0 0 0 0
EPS -1.68 -2.76 -1.69 -0.93 -0.63
EPS Diluted -1.68 -2.76 -1.69 -0.93 -0.63
Weighted Average Shares Out $73.79 M $44.82 M $41.29 M $41.12 M $41.12 M
Weighted Average Shares Out Diluted $73.79 M $44.82 M $41.29 M $41.12 M $41.12 M
Link